File: PDF (376 Ko)
This document details the in vivo use of FlashRNA® via intradermal administration for base editing, successfully correcting the LMNA gene mutation linked to Hutchinson-Gilford progeria syndrome (HGPS) in a mouse model. The study demonstrates efficient gene editing and improved skin tissue phenotype following FlashRNA® injection.
®copyright RNAlead® 2025 – Propulsed by WS Interactive